| Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma J Okosun, C Bödör, J Wang, S Araf, CY Yang, C Pan, S Boller, D Cittaro, ... Nature genetics 46 (2), 176-181, 2014 | 754 | 2014 |
| EZH2 mutations are frequent and represent an early event in follicular lymphoma C Bödör, V Grossmann, N Popov, J Okosun, C O’Riain, K Tan, J Marzec, ... Blood, The Journal of the American Society of Hematology 122 (18), 3165-3168, 2013 | 353 | 2013 |
| Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma J Okosun, RL Wolfson, J Wang, S Araf, L Wilkins, BM Castellano, ... Nature genetics 48 (2), 183-188, 2016 | 234 | 2016 |
| Disease evolution and outcomes in familial AML with germline CEBPA mutations K Tawana, J Wang, A Renneville, C Bödör, R Hills, C Loveday, A Savic, ... Blood, The Journal of the American Society of Hematology 126 (10), 1214-1223, 2015 | 211 | 2015 |
| HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the … S Montoto, K Shaw, J Okosun, S Gandhi, P Fields, A Wilson, M Shanyinde, ... Journal of clinical oncology 30 (33), 4111, 2012 | 168 | 2012 |
| Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma S Araf, J Wang, K Korfi, C Pangault, E Kotsiou, A Rio-Machin, T Rahim, ... Leukemia 32 (5), 1261-1265, 2018 | 111 | 2018 |
| Clinical outcome of coronavirus disease 2019 in haemato‐oncology patients JA Aries, JK Davies, RL Auer, SL Hallam, S Montoto, M Smith, B Sevillano, ... British journal of haematology 190 (2), e64, 2020 | 102 | 2020 |
| Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma L Mansouri, D Noerenberg, E Young, E Mylonas, M Abdulla, M Frick, ... Blood, The Journal of the American Society of Hematology 128 (23), 2666-2670, 2016 | 98 | 2016 |
| Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors SJ Horton, G Giotopoulos, H Yun, S Vohra, O Sheppard, ... Nature cell biology 19 (9), 1093-1104, 2017 | 69 | 2017 |
| Follicular lymphoma: recent and emerging therapies, treatment strategies, and remaining unmet needs MJ Matasar, S Luminari, PM Barr, SK Barta, AV Danilov, BT Hill, ... The oncologist 24 (11), e1236-e1250, 2019 | 55 | 2019 |
| Oncogenic Rag GTPase signalling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR A Ortega-Molina, N Deleyto-Seldas, J Carreras, A Sanz, ... Nature metabolism 1 (8), 775-789, 2019 | 49 | 2019 |
| Pathogenesis of follicular lymphoma: genetics to the microenvironment to clinical translation E Kumar, L Pickard, J Okosun British Journal of Haematology 194 (5), 810-821, 2021 | 42 | 2021 |
| KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas J Heward, L Koniali, A D’Avola, K Close, A Yeomans, M Philpott, ... Blood, The Journal of the American Society of Hematology 138 (5), 370-381, 2021 | 39 | 2021 |
| TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses E Kotsiou, J Okosun, C Besley, S Iqbal, J Matthews, J Fitzgibbon, ... Blood, The Journal of the American Society of Hematology 128 (1), 72-81, 2016 | 34 | 2016 |
| IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution M Odabashian, E Carlotti, S Araf, J Okosun, F Spada, JG Gribben, ... Blood, The Journal of the American Society of Hematology 135 (11), 834-844, 2020 | 28 | 2020 |
| Epigenetic dysregulation in follicular lymphoma S Araf, J Okosun, L Koniali, J Fitzgibbon, J Heward Epigenomics 8 (1), 77-84, 2016 | 27 | 2016 |
| The routes for transformation of follicular lymphoma J Okosun, S Montoto, J Fitzgibbon Current opinion in hematology 23 (4), 385-391, 2016 | 23 | 2016 |
| Interim fluoro-2-deoxy-D-glucose–PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection J Okosun, V Warbey, K Shaw, S Montoto, P Fields, R Marcus, A Virchis, ... Aids 26 (7), 861-865, 2012 | 23 | 2012 |
| Thyroid MALT lymphoma: self-harm to gain potential T-cell help F Wu, N Watanabe, MM Tzioni, A Akarca, C Zhang, Y Li, Z Chen, F Cucco, ... Leukemia 35 (12), 3497-3508, 2021 | 19 | 2021 |
| Ncri petrea trial: a phase 3 evaluation of pet‐guided, response‐adapted therapy in patients with previously untreated, advanced‐stage, high‐tumour‐burden follicular lymphoma AR Pettitt, S Barrington, N Kalakonda, UT Khan, R Jackson, S Carruthers, ... Hematological Oncology 37, 67-68, 2019 | 14 | 2019 |
Jude FitzgibbonQueen Mary University of LondonПотвърден имейл адрес: qmul.ac.uk
